Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Smith

Showing results (41-50 of 125) with videos related to

Pageof 13
Sort By:
PM & R : the Journal of Injury, Function, and Rehabilitation|September 28, 2016
Poster 427 Pharmacodynamic Effects From a Category 3 Intranasal Human Abuse Potential Study of an Abuse-Deterrent, Extended-Release Morphine Product Candidate in Nondependent, Recreational Opioid UsersLynn R Webster, Michael D Smith, John Lawler, et al.
Pain Medicine (Malden, Mass.)|September 17, 2016
Human Abuse Potential of an Abuse-Deterrent (AD), Extended-Release (ER) Morphine Product Candidate (Morphine-ADER Injection-Molded Tablets) versus Extended-Release Morphine Administered Orally in Nondependent Recreational Opioid UsersMichael D Smith, Lynn R Webster, John Lawler, et al.
Annals of Emergency Medicine|June 21, 2011
A comparison of patient and staff attitudes about emergency department-based HIV testing in 2 urban hospitalsCarrie R Hecht, Michael D Smith, Karina Radonich, et al.
Pain Medicine (Malden, Mass.)|September 22, 2016
Human Abuse Potential of an Abuse-Deterrent (AD), Extended-Release (ER) Morphine Product Candidate (Morphine-ADER Injection-Molded Tablets) vs Extended-Release Morphine Administered Intranasally in Nondependent Recreational Opioid UsersLynn R Webster, Michael D Smith, John Lawler, et al.
The Journal of Clinical Psychiatry|February 9, 2012
An 8-week, randomized controlled trial of atomoxetine, atomoxetine plus buspirone, or placebo in adults with ADHDSuzanne M Sutherland, Lenard A Adler, Crystal Chen, et al.
Annals of Emergency Medicine|July 12, 2013
Clinical policy: critical issues in the evaluation and management of adult patients in the emergency department with asymptomatic elevated blood pressureStephen J Wolf, Bruce Lo, Richard D Shih, et al.
Culture, Health & Sexuality|June 12, 2014
Male clients' behaviours with and perspectives about their last male escort encounter: comparing repeat versus first-time hiresMargaret M Wolff, Christian Grov, Michael D Smith, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 27, 2020
Pharmacokinetics and Catabolism of [<sup>3</sup>H]TAK-164, a Guanylyl Cyclase C Targeted Antibody-Drug ConjugateJayaprakasam Bolleddula, Abhi Shah, Mohammad Shadid, et al.
Pain Medicine (Malden, Mass.)|April 3, 2018
A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Intranasal Human Abuse Potential Study of Oxycodone ARIR, a Novel, Immediate-Release, Abuse-Deterrent FormulationLynn R Webster, Matthew Iverson, Carmela Pantaleon, et al.
The Journal of Emergency Medicine|June 22, 2011
The effectiveness and adverse events of morphine versus fentanyl on a physician-staffed helicopterMichael D Smith, Yang Wang, Michael Cudnik, et al.
Pageof 13

Showing results (41-50 of 125) with videos related to

Sort By:
Pageof 13
PM & R : the Journal of Injury, Function, and Rehabilitation|September 28, 2016
Poster 427 Pharmacodynamic Effects From a Category 3 Intranasal Human Abuse Potential Study of an Abuse-Deterrent, Extended-Release Morphine Product Candidate in Nondependent, Recreational Opioid UsersLynn R Webster, Michael D Smith, John Lawler, et al.
Pain Medicine (Malden, Mass.)|September 17, 2016
Human Abuse Potential of an Abuse-Deterrent (AD), Extended-Release (ER) Morphine Product Candidate (Morphine-ADER Injection-Molded Tablets) versus Extended-Release Morphine Administered Orally in Nondependent Recreational Opioid UsersMichael D Smith, Lynn R Webster, John Lawler, et al.
Annals of Emergency Medicine|June 21, 2011
A comparison of patient and staff attitudes about emergency department-based HIV testing in 2 urban hospitalsCarrie R Hecht, Michael D Smith, Karina Radonich, et al.
Pain Medicine (Malden, Mass.)|September 22, 2016
Human Abuse Potential of an Abuse-Deterrent (AD), Extended-Release (ER) Morphine Product Candidate (Morphine-ADER Injection-Molded Tablets) vs Extended-Release Morphine Administered Intranasally in Nondependent Recreational Opioid UsersLynn R Webster, Michael D Smith, John Lawler, et al.
The Journal of Clinical Psychiatry|February 9, 2012
An 8-week, randomized controlled trial of atomoxetine, atomoxetine plus buspirone, or placebo in adults with ADHDSuzanne M Sutherland, Lenard A Adler, Crystal Chen, et al.
Annals of Emergency Medicine|July 12, 2013
Clinical policy: critical issues in the evaluation and management of adult patients in the emergency department with asymptomatic elevated blood pressureStephen J Wolf, Bruce Lo, Richard D Shih, et al.
Culture, Health & Sexuality|June 12, 2014
Male clients' behaviours with and perspectives about their last male escort encounter: comparing repeat versus first-time hiresMargaret M Wolff, Christian Grov, Michael D Smith, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 27, 2020
Pharmacokinetics and Catabolism of [<sup>3</sup>H]TAK-164, a Guanylyl Cyclase C Targeted Antibody-Drug ConjugateJayaprakasam Bolleddula, Abhi Shah, Mohammad Shadid, et al.
Pain Medicine (Malden, Mass.)|April 3, 2018
A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Intranasal Human Abuse Potential Study of Oxycodone ARIR, a Novel, Immediate-Release, Abuse-Deterrent FormulationLynn R Webster, Matthew Iverson, Carmela Pantaleon, et al.
The Journal of Emergency Medicine|June 22, 2011
The effectiveness and adverse events of morphine versus fentanyl on a physician-staffed helicopterMichael D Smith, Yang Wang, Michael Cudnik, et al.
Pageof 13